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Abstract 
The spread of antibiotic resistance among bacteria has shown that the development of 
alternative treatments of infections is of vital importance. This thesis has looked at one potential 
candidate, antimicrobial peptides (AMPs), as an alternative or compliment to traditional 
antibiotics. AMPs are short peptides, normally just 10-25 amino acids long, that are part of our 
own innate immune system. Their mode of action to eradicate bacteria is most commonly by 
the disruption of the membrane of the bacteria. This mode of action makes it difficult for the 
bacteria to develop a resistance against AMPs, as it would require a fundamental change of 
their membrane structure. The challenge with using AMPs is their sensitivity towards 
proteolytic degradation when in a biological environment containing proteolytic enzymes. This 
thesis has used covalent attachment to a material as a means to increase this stability. 
A wound bed is a haven for opportunistic pathogens and regardless of if it is caused by trauma 
or a surgical incision, bacteria that finds their way into a wound need to be dealt with in order 
to prevent an infection. Two approaches have been investigated in this thesis, with wound 
management as the application in mind. In the first approach, soft hydrogels were made out of 
the block copolymer Pluronic F-127 diacrylate. The polymer self-assembled into lyotropic 
liquid crystals which in turn were cross-linked in place. To these hydrogels, the antimicrobial 
peptide RRPRPRPRPWWWW-NH2 was covalently attached. This resulted in a non-toxic 
material consisting of 90 wt% water with an antibacterial surface active against the clinically 
relevant strains of bacteria S. aureus, S. epidermidis, and P. aeruginosa. It also showed good 
antibacterial effect against the antibiotic resistant strains MRSA and MDR-E. coli. In addition, 
this method increased the stability of the peptides against proteolytic degradation in serum. 
The second approach focused on the development of particles using the same material 
foundation as the first approach. Particles were chosen in order to increase the antibacterial 
potential as well as obtaining a material suitable for applications where a liquid formulation is 
desired. The produced particles had a high antibacterial effect both in solution as well as in a 
slurry. For the slurry, the bacterial load of S. aureus in an agar plate model was reduced by 
99.99%. Cryogenic electron microscopy experiments indicated that the mechanism of action 
for the AMP-modified particles indeed was due to interaction with the bacterial cell 
wall/membrane. 
 
Keywords: Antimicrobial peptides, hydrogels, self-assembly, lyotropic liquid crystals, 
antibacterial surface, Pluronic F-127  
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The human body is a marvelous thing, consisting of trillions of individual microscopic cells 
that are working in unity to achieve movement, thinking, digestion, defense, and a number of 
other features. It even has the ability to repair itself: when DNA does not get copied correctly 
there are enzymes that repair it [2]. When trauma causes blood vessels to rupture and form 
bruises, the cells in the body stops the internal bleeding and rebuild the blood vessels [3]. But 
the human body is not perfect. Sometimes things go wrong to such an extent that the repair 
system cannot handle the damage and needs help. If the DNA damage for example becomes 
too severe for the body to handle, it can lead to tumor formation, which can have a devastating 
effect. If an acute trauma is so great that a large wound is formed, the body might not be able 
to stop the bleeding by itself and might not be able to heal the wound without some assistance. 
Luckily, millennia of development of healthcare and medicine has done wonders for treating 
both disease and acute trauma. Humans have never had a higher life expectancy than today, 
and a number of earlier untreatable conditions are now treatable. Some diseases have even been 
eradicated. One thing that has been crucial for this progress is antibiotics. Bacteria have been 
present throughout our history, causing infections that have been killing people and impairing 
peoples’ lives. When breaches of the skin or other defense systems of our bodies are too large, 
bacterial infection can arise. Antibiotics have made it possible to treat these conditions 
effectively in ways that were not possible before. However, the emergence of antibiotic 
resistant bacteria is threatening to nullify this development. Alternatives to antibiotics are 
therefore in high demand, and one promising alternative is antimicrobial peptides.  
The aim of this thesis was to evaluate the incorporation of antimicrobial peptides to soft 
hydrogels for applications within wound care. Two approaches (illustratively shown in Figure 
1) were taken for this:  
 
- Soft hydrogel sheet made from non-toxic polymers self-assembled into lyotropic liquid 
crystals that were then cross-linked into shape. Antimicrobial peptides were then 
covalently attached to the surface of these lyotropic liquid crystals. Potential application 
for this could be as a wound dressing. 
 
- Particles made of lyotropic liquid crystals post-modified with antimicrobial peptides. 
Compared to sheets, particles were prepared to get a higher antimicrobial surface while 







Figure 1. The two concepts used in this thesis to produce antibacterial materials. Both the hydrogel sheets (top 
left) and the particles (bottom left) are built up by amphiphilic polymers that have self-assembled into a micellar 
cubic phase (middle). The sheets and particles were subsequently cross-linked into shape and modified with 
covalently attached antimicrobial peptides (far right). The red in the structure represents the hydrophobic 
polypropylene oxide region of the polymer, the blue represents the hydrophilic polyethylene oxide region of the 





To better understand the concept of this thesis, I have broken down the background into four 
sections depicting the ongoing battle that the cells in our bodies are going through against the 
elements of our surroundings. 
 
2.1. The battleground 
 
Our bodies most important defense system is also our largest organ, the skin. It consists of 
several layers which each has its own unique function. Outmost, at the very surface, we find 
the epidermis, consisting almost completely of a monoculture of keratinocytes. The 
keratinocytes proliferate from basal cells and then goes through cell differentiation, in which 
they become highly ordered while also forming tight junctions which connects them tightly to 
each other [4]. They also produce keratin, which together with the cells and an extracellular 
lipid layer form a layer that works as a barrier towards even the smallest molecules [5]. This 
helps containing water and heat inside of our bodies while keeping pathogens out.  
Beneath the epidermis lies the dermis. This layer consists of connective tissue built up by 
structural components like collagen, elastin, and hyaluronic acid. This gives the skin its 
elasticity and cushions the body somewhat [6]. Hair cells, heat receptors, nerve cells and blood 
vessels are also found in the dermis. The major cell groups found here are fibroblasts, whose 
main function is to synthesize the extracellular matrix components [7]; macrophages, whose 
main function is to neutralize threats if a breach in the epidermis is formed [8]; and mast cells, 
whose main function is to activate the immune system when a threat is detected, but also to 
activate wound healing [9].  
Beneath the dermis lies the subcutaneous tissue. Its function is to connect the layers above to 
underlying muscle and bones and consists of connective tissue along with fat cells [10]. The 
subcutaneous tissue also cushions the internal organs and provides some insulating effect.  
With this in mind, it is apparent that damage to the skin can result in several serious conditions. 
The first noticeable thing is that blood will be pouring out if blood vessels are ruptured. In 
major trauma this can lead to exsanguination. Higher degree burns can cause damage to the 
dermis so severe that it results in a permanent loss of sensitivity, inability to control body 
temperature and inability to prevent water loss through evaporation [11]. Damage to the skin 
will also give pathogens access to internal parts previously protected. However, as mentioned 
before, the body has the ability to repair itself, and wound healing is a well-oiled machinery. 
Generally, the wound healing is broken down into four stages: coagulation, inflammation, 
proliferation, and remodeling. The most acute problem to deal with is to stop the bleeding, 
which is what the coagulation does. Through platelet activation and fibrin formation, blood 
clots are formed, which effectively clogs up the bleeding [12]. The next stage is inflammation, 
which deals with cleaning up the wound. This is done by leukocytes, which remove debris, 
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clear out damaged tissue and cells, and deal with potential pathogens [13]. Some leukocytes 
also release cytokines which attract other cells to the site in order to start the third stage: 
proliferation. In this stage the tissue is built up again: blood vessels are formed by angiogenesis 
[14], connective tissue is produced by fibroblasts, and the epidermis is formed by epithelial 
cells migrating into the non-covered area [15]. The final part is the remodeling of the wound, 
where unnecessary cells are removed, and the collagen is remodeled into stronger bundles [16]. 
Due to this well-tuned wound healing process, most drugs and medical devices try not to 
interfere with the wound healing but instead try to optimize the conditions for its function. One 
of the most important features of any kind of wound dressing is to replace the broken barrier 
that provide shelter from the outside [17]. Having an external barrier also helps keeping the 
wound moist by hindering evaporation. This is why even the simplest plaster can be quite 
effective at giving a wound a good environment for healing. More extensive wounds, however,  
can have a trickier time healing in a good way, and more advanced help might be required. If 
a child falls and scratches up their knee for instance, there most likely will be dirt or gravel in 
the wound. Manual debridement of such wounds will help the healing significantly while also 
lowering the risk of pathogens gaining access to the underlying tissue. For deep gashes, the 
healing can be greatly helped by stitching the wound together (after debridement, if necessary), 
which will put things back in place while also covering up the wound and minimizing the gap 
that needs to be healed. For large burn wounds, soft hydrogels or hydrocolloids with a high 
water content can be used. These have shown to give pain relief for patients while also giving 
the wound a moist environment, which improves healing rate significantly [18].  
There are a high variety of dressings designed for various types of wounds. Some dressings 
even incorporate active substances aimed at enhancing certain aspects of the wound healing 
process. The substances could be antimicrobials, aimed at preventing microbial organisms from 
infecting the wound [19-21], it can be growth factors, aimed at increasing certain activity of 
certain cells [22, 23], or it can be supplements, aimed at providing the cells of the wound 
healing process with everything they need in order to do their best job possible [24, 25]. 
 
2.2. Invading forces 
 
As mentioned before, a lot of the functions of the skin and wound management involves 
protection from microbes, and there is a good reason for this. Microbes are an ancient form of 
organisms, speculated to have been the very first form of life found on earth. And they are ever-
present. They exist in numerous forms and at all places on earth. Most important for this thesis 
are bacteria. Bacteria sometimes gets a bad reputation, but under normal conditions they are 
great allies of humans. We have an extensive flora of microbes in our guts for instance – 
consisting mainly of bacteria – called the gut microbiota. The human body serves as a host for 
the microbiota, providing it with a steady flow of nutrients, and the microbiota are metabolizing 
nutrients that our own cells cannot deal with on their own. The microbiota even synthesize 
important elements that we need to function properly but cannot synthesize by ourselves [26]. 
Bacteria are also present on our skin, and each human has their own flora of bacteria. The 
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bacteria found on the skin are normally not harmful and can even provide some benefits for us 
by essentially keeping the harmful bacteria away [27].  
However, when a breach in the skin barrier occurs, bacteria can find their way into the wound 
bed and that is a different story. What has kept microbes around all these years is their fantastic 
ability to adapt to new situations. When a new environments appears, bacteria will try to take 
advantage of the change and colonize the environment, especially a habitat as cozy and rich in 
nutrients as a wound bed [28]. This kind of process is called an opportunistic infection. It 
therefore does not come as a big surprise that the bacteria most commonly found in wound 
infections are also bacteria found in our normal skin flora [29-31].  
Our bodies have several mechanisms to combat intruding bacteria. Directly after a breach and 
pathogenic invasion there is a rapid response that is non-specific and broad-spectrum. This is 
part of the innate immune system. The cells that are part of the innate immune system will try 
to neutralize intruding pathogens by lysing them, ingesting them, or kill infected cells [32, 33]. 
During this process they will also gather information about the intruding pathogens, and by 
gathering the antigens specific to the pathogen, the adaptive immune system can be activated 
[34]. The adaptive immune system can target specific pathogens more effectively by the use of 
antibodies that are sensing the antigens specific to the pathogen. By saving these antibodies in 
specific memory cells, the adaptive immune response towards specific pathogens can be 
quicker and elevated for the next time the same pathogen invades the host. 
However, if the microbial load is too high, or if the immune system is compromised, it might 
lead to an infection that needs external help. Luckily, almost 100 years ago, arguably the most 
important discovery for modern medicine was discovered: penicillin, the first antibiotic. 
Antibiotic is a term for substances that are used in medicine to treat bacterial infections. The 
mechanism for antibiotics is very diverse but generally it inhibits a very specific function in 
the bacterium that can either kill it or stop its growth [35]. The positive thing with this 
specificity is that it can be very effective and still not harm human cells. The negative thing 
with the specificity is that changes in the targeted site will render it useless. This means that 
mutations in the bacterium DNA can make the bacterium resistant to certain antibiotics [36]. 
By removing antibiotics by specific efflux pumps from the inside of the bacterium to the 
outside or by hydrolyzing parts of the antibiotics, bacteria can also lower the concentration to 
none-lethal levels [36]. This causes what is known as antibiotic resistance. Whenever a new 
antibiotic has been introduced, it has not taken long before resistant strains have been found. 
Due to bacteria’s ability to perform horizontal gene transfer, even between species, resistance 
can and have spread to the extent that some infections are again untreatable [37]. It is therefore 
of utmost importance to find alternatives or compliments to antibiotics. For instance, one of 
the oldest known antimicrobial agents is honey, and in some forms, it is still used in medicine 
today. Compounds in honey have shown to reduce microbial growth while also aiding the 
wound healing [38, 39]. However, the antibacterial effect is not that great when compared to 
other alternatives and producing honey in large quantities can prove difficult. Another 
compound that has been used for a long time in order to deal with bacterial infection is ionic 
silver. Today it is mainly used as nanoparticles and it is a highly effective antibacterial 
substance [40]. It has been incorporated into wound dressings, ointments and even textiles [21, 
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41, 42]. However, there is an ongoing discussion regarding the toxicity silver has towards 
mammalian cells [43, 44]. Moreover, silver needs to be eluted into the media where the bacteria 
are found, which limits its applications.  
 
2.3. The (potential) savior 
 
One promising alternative to traditional antibiotics is antimicrobial peptides (AMPs). These 
are short chains of amino acids, normally just 10-25 amino acids long. AMPs have been used 
to combat bacterial infections for millennia, since they are a part of the innate immune response 
of a lot of organisms, ours included [45]. They exist in a large variety of structures and they 
can also target different components of the bacteria. What differentiate them from antibiotics 
is that they target a general structure and not a specific site, which means that resistance is 
much more improbable [45, 46]. The target for AMPs is generally the cell wall or the outer 
membrane of the bacteria [47], which makes resistance even more difficult to evolve since 
efflux pumps would be useless. This mechanism also gives the AMPs their specificity towards 
bacteria, since both gram negative and gram positive bacteria have negatively charged surfaces 
due to the lipopolysaccharides in gram negative bacteria and the teichoic acid in gram positive 
bacteria [46]. AMPs therefore generally have a positively charged section and a hydrophobic 
section. The secondary structure is usually an alpha-helix, which is sometimes formed by 
structural changes first when the peptide comes in contact with a membrane [48]. This gives 
the AMPs an attractiveness towards the negatively charged bacterial surface that it does not 
have towards the neutrally charged surface of the majority of mammalian cells. The peptides 
are suggested to exert their antimicrobial effect by forming pores in the membrane or by 
disintegrating parts of it in a surfactant-like manner [46, 49].  
The main reason AMPs have not had a bigger impact in medicine is that they are very sensitive 
to proteolytic degradation [50]. This means that they have a very short life span once they are 
inside our bodies. This is fine if there are leukocytes around to continuously deliver a supply 
of peptides [51], which will also provide a local treatment. But it poses real difficulties for the 
incorporation into treatment options. There have been a few different approaches to deal with 
this issue throughout the last decades. Some research has been made to modify the base 
structure, where the amino acids has been changed from the regular L-configuration to the less 
commonly found D-configuration [52]. This will protect the peptides since the reaction siters 
on the enzymes that perform the proteolysis can normally only target the L-configuration. 
Others have tried to incorporate it into drug delivery systems which protects the peptides until 
they are released [53, 54]. The method used in this thesis is to bind the AMPs to a surface. By 
having the peptides bound to a surface it is hypothesized that this will sterically hinder the 
enzymes from gaining access to the cleaving sites, which in turn means that the AMPs can last 
longer in biological solutions containing proteolytic enzymes. There are several ways of doing 
this, and depending on the base material one has, different chemistries can be used. Important 
to keep in mind is that some studies have shown that some peptides lose their activity when 
bound to a surface [55, 56]. Also, the activity of some peptides can be strongly dependent on 
the inclusion of a spacer between the base material and the peptide [56, 57]. Furthermore, the 
orientation of the peptide while attached to the surface might also affect the potency of the 
antibacterial effect [58, 59], and should therefore be taken into consideration. It is of course of 
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outmost importance to also pick a peptide that does not need to get access to the intracellular 
matrix to exert its antibacterial effect. Due to these reasons, in this thesis, the AMP of choice 
is a synthetically made one with the structure RRPRPRPRPWWWW-NH2. The structure for 
this can be seen in Figure 2. This peptide is very short with a heavily charged section and a 
section that is very hydrophobic. The secondary peptide structure is unknown but due to the 
short length, high proline content, and localized sections, any complicated structure is unlikely. 
The carboxyl group on the C-terminal has been blocked off by forming an amide group, giving 
the peptide an overall charge of +6 at physiological pH. In this thesis, the attachment is done 
by EDC/NHS coupling, which means that the primary amine group at the N-terminal is 
covalently attached to a carboxylic acid group found at the base material. This results in a zero-




2.4. Presenting the savior 
 
Depending on the application, the material foundation can be tuned to match the desired 
properties. In this thesis, a soft hydrogel with available carboxyl groups was desired in order 
to have a site for the AMP modification, as well as being comfortable if turned in to a wound 
dressing. For the synthesis of the hydrogel, the triblock copolymer Pluronic™ F127 was 
chosen, since it is regarded as not toxic, is FDA approved for some uses in vivo and is easily 
functionalized [60-62]. Furthermore, Pluronics have an amphiphilic structure and function as 
polymeric surfactants that self-assemble into lyotropic liquid crystals (LLCs) in solution 
(illustrated in Figure 3b) [1]. This means that the structure can be fine-tuned by changing 
concentration and type of solvent, as shown in Figure 3a. By modifying the ends of the Pluronic 
with the addition of acrylate groups, the LLCs can be cross-linked into place by exposure to 
UV radiation (with the addition of a photo-initiator). By further exposure to UV radiation or 
by simple hydrolysis, the formed ester bonds can be broken down to the desired carboxylic 
acids [63, 64]. Cross-linking will occur between the endpoints of the Pluronic molecules, which 
will be located at the outer points of the LLCs. It is therefore likely that the formed carboxylic 
Figure 2. The structural formula at physiological pH of the synthetically produced antimicrobial peptide used in 
this study.  The peptide consists solely of arginine, proline and tryptophan and the C-terminal have been modified 
to end on an amide group. 
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acid groups also will be located here. This means that the EDC/NHS will attach the AMPs 
mainly to the outer parts of the structures as illustrated in Figure 4.  
F127 is one of the Pluronics with the highest hydrophilic portions, and in polar solvents this 
results in ‘normal’ phases with the hydrophobic parts tucked away inside the structures, 
illustrated in Figure 4. This opens up for the potential of loading the system with for example 
pharmaceutics for drug-delivery [65, 66]. Non-polar molecules can be loaded into the 
hydrophobic parts of the structures and polar molecules can be loaded into the hydrophilic parts 
of the structure. The release profile will be a bit different depending on where drugs are loaded, 
with a bigger initial burst of release from the hydrophilic section. Furthermore, when cross-
linked into a hydrogel, the material should be able to swell by taking up water while still 
retaining the highly ordered structure. A wound dressing made out of this high water content  
material is suitable for wounds to keep them moist, which improves wound healing and 
increase the comfort for the wearer [18]. This kind of material is, however, not suitable for 
wounds with heavy exudate, since this might lead to maceration [67]. Furthermore, Pluronic 
shows no negative effect on mammalian cells in a 5% w/w solution, indicating that potential 
residues or applications in the blood or tissue can be performed in a non-harmful manner [68]. 
Further benefits from using Pluronic is that it is synthetically produced, meaning that it is easy 
to make in a scalable manner, which makes it more cost effective. 
 
 
Figure 3. (a) Phase diagram of water, Pluronic F127 and 1-Butanol. L1 stand for micellar solution, I1 stand for 
normal micellar cubic phase, Lα stand for lamellar phase, L2 stand for reverse micellar solution and H1 stand for 







Figure 4. Illustration of micellar formation by Pluronic F-127 that is cross-linked into place, with the consecutive 
AMP modification of the carboxylic acid groups at the end of the Pluronic molecules. The hydrophobic section is 
represented as the red core of the micelles, the hydrophilic section is represented as the blue shell, and the AMP 







In the following section, the methods and techniques used in the thesis are shortly described in 
terms of why and how they were used. For more exact information regarding the procedure, 
please check the experimental sections of Paper 1 and Paper 2. 
 
3.1. Producing the materials 
 
The Pluronic F127 diacrylate was mixed with water and photoinitiator at concentrations that 
corresponds to the micellar cubic phase of the phase diagram, denoted as I1 in Figure 3. For the 
hydrogel sheets used in Paper 1, the formed gels were spread between two glass slides and 
stored sealed away overnight in order for the polymers to set into the micellar cubic phase. For 
the  production of particles in Paper 2, the mixed gels were placed at 4°C for at least 2 days 
before being placed between glass slides. The gels were then cross-linked into solid hydrogels 
by exposure to UV radiation (λ=302 nm). The hydrogels were then washed for at least two 
days and could then be modified by covalently attaching AMPs by EDC/NHS coupling.  
In order to make the particles that Paper 2 is based on, the cross-linked hydrogels were first 
washed in water to remove non-cross-linked polymer and initiator. Then they were blended 
into fragments and then reduced further in size by using an ultra-turrax and sonication. The 
obtained mixture could then be separated into size by filtration and modified with AMPs by 
EDC/NHS coupling. The particles could then also be freeze-dried in order to get a fine powder 
devoid of water that could be stored for longer times and re-swollen rapidly if necessary.  
 
3.2. Material characterization 
 
In order to analyze the water content and swelling potential, the produced materials of both 
Paper 1 and 2 were put through several cycles of swelling and drying with weigh in after each 
step. The effectiveness of the peptide modification was evaluated by UV-vis measurements. 
This was possible due to the presence of tryptophan in the peptide, which has a distinct 
absorbance at 280 nm. For both sheets and particles the peptide concentration in the 
surrounding liquid after modification was measured and compared to the stock solution. This 
gives the amount of peptides that may have covalently conjugated with the hydrogels during 
post modification of the materials. 
To acquire information about the chemical composition of the materials developed in Paper 2, 
Fourier transform infra-red spectroscopy (FTIR) and Raman spectroscopy were used. The 
purpose of using these methods was to gain more knowledge about the differences in between 
sample types and to verify the covalent attachment of the peptides. FTIR measures the 
molecular vibrations of a material that is exposed to infra-red light. This gives a spectrum from 
which the molecular composition can be found since molecules vibrate at specific energy levels 
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due to absorption of light in the infra-red region, resulting in molecular specific peaks. Raman 
spectroscopy works similarly by aiming a laser at the sample and measuring the molecular 
specific Raman scattering, resulting in a spectrum with a molecular fingerprint of the sample. 
Both Raman and FTIR were used since different bonds appear stronger in one of the techniques 
compared to the other. In this way the two techniques complement each other which could help 
paint a clearer picture on the nature of the peptide hydrogel interaction. 
In Paper 2, small-angle X-ray scattering (SAXS) was used to obtain nano structural information 
of the self-assembled LLCs formed by the Pluronic F127 polymer. Materials with an ordered 
structure, when irradiated with X-rays, will scatter the same in a specific scattering pattern 
which can be picked up by a detector. This makes it possible to detect repeating structures in 
the material such as cubic ordered micellar structures or hexagonally ordered micellar fibrils. 
By analyzing the obtained spectrum and comparing it to known LLC structures, it is possible 
to determine the phase of the lyotropic liquid crystals in the sample. The purpose of using 
SAXS was to investigate whether the structure was maintained throughout the processing of 
the LLCs, both in its macroscopic sheet form and particle form.  
In order to analyze the size distribution of the particles developed in Paper 2, dynamic light 
scattering (DLS) was used. By measuring the duration and intensity of the scattering of a laser 
aimed at a solution, the size and amount of particles in the solution can be determined by using 
the fact that the particles in the solutions are undergoing Brownian motion. From this, it is 
possible to get information on the size distribution of the particles, and consecutive runs can 
even give some information regarding the behavior of the particles, in terms of stability. 
 
3.3. Antibacterial efficacy 
 
The antibacterial effect was evaluated against the following bacterial strains: Staphylococcus 
aureus, Staphylococcus epidermidis, Escherichia coli, Pseudomonas aeruginosa, Methicillin 
resistant S. aureus (MRSA), and multidrug-resistant E. coli (MDR-E.coli).  
For the sheets developed in Paper 1, the antibacterial effect was evaluated by culturing the 
sheets together with bacteria in tryptic soy broth (TSB) for 24 hours. The samples were then 
washed with phosphate buffered saline (PBS) and the top surface was then stained with 
LIVE/DEAD staining. This stain contains two components; SYTO-9 which is membrane 
permeable and can therefore enter all cells in which it attaches to genetic material and can here 
be fluorescently activated to emit green light. The other component is propidium iodine which 
is not membrane permeable and can therefore only enter dead cells with a compromised 
membrane. When inside the cell it will also attach to genetic material and can be fluorescently 
activated to emit a red light. With this staining it is therefore possible to get an observable 
difference between alive and dead cells with the help of a fluorescence microscope. The 
obtained images can with software analysis give a number on the proportion of dead and alive 
bacteria on a surface. When compared to non-modified hydrogel sheets, the effectiveness of 
the peptides can then be determined.  
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The antimicrobial effect of the particles (Paper 2) was evaluated in two different ways; by 
minimum inhibitory concentration (MIC) tests and by an agar plate model. In the MIC test, 
solutions can be tested and, in this case, pure AMP and particles were tried. The solutions were 
serial diluted by a factor of two in a well plate, and a known concentration of bacteria was 
added to each well followed by incubation overnight. In the dilution in which no growth was 
visible the following day is the lowest concentration that is necessary to inhibit the growth of 
the bacteria and is called the minimum inhibition concentration. This is a clear and rather fast 
method to determine the effectiveness of an antimicrobial agent. The agar plate model was 
performed by making slurries of the particles in PBS which were then spread on agar plates 
where bacteria has been spread just prior. The agar plates were then incubated overnight, and 
the following day sections in the middle of the spread were obtained with the use of biopsy 
punches. The sections were then placed in PBS and thoroughly mixed followed by serial 
dilutions which were placed on agar plates and incubated overnight. The following morning 
the colonies formed were counted and the original bacterial concentration was calculated. 
When compared to the non-modified control particles, the antibacterial effect by the addition 
of AMPs could be evaluated. 
To evaluate the covalent attachment of the peptide by the EDC/NHS coupling, a zone of 
inhibition study was performed (Paper 1). Hydrogel discs were modified either with EDC/NHS 
activation followed by AMP modification or by just placing them in the peptide solution in an 
attempt to physically load the LLCs with peptides. Just as in the agar plate model, bacteria 
were spread on to an agar plate and the disc were then placed on top and the plates were 
incubated overnight. The following morning, images were taken of the plates to evaluate any 
potential zone of inhibition around the hydrogel discs, which would indicate that there was a 
release of peptides occurring from the hydrogels. 
In order to gain knowledge regarding the mechanism of action of the particles against bacteria, 
cryogenic transmission electron microscopy (cryo-EM) studies were performed in Paper 2. 
Syringe-filtrated particles (<0.22 µm) were AMP-modified and incubated with S. aureus for 1 
hour. The solution was then plunge frozen in liquid ethane to preserve any biological 
interactions and viewed with a transmission electron microscope (TEM) under cryo-conditions.  
 
3.4. Proteolytic stability 
 
The antibacterial stability of the peptides attached to the hydrogel sheets were evaluated by 
placing AMP-modified hydrogels in serum and then taking them out from the serum at certain 
time intervals. As described in Paper 1. The hydrogel sheets were then washed and placed in 
well plates and incubated together with S. aureus for 24 hours and were then stained with 
LIVE/DEAD staining and imaged with fluorescence microscopy. The proportion of dead cells 
were then plotted against time and when compared to the non-modified control hydrogels the 




3.5. Cytotoxicity  
 
In order to make sure that no adverse effects of the manufactured materials of Paper 1 were 
seen, in terms of being harmful to mammalian cells, cytotoxicity studies were implemented. 
More specifically, a method called MTT-assay was performed. For this, the hydrogels were 
placed in cell media at 37 °C for 3 days. The hydrogels were then removed by simply taking a 
tweezer and plucking them out. The sample exposed media was then placed in well plates to 
which a certain number of cells was added. The cells used was primary human dermal 
fibroblasts since it is vital that these cells are not affected for a potential wound care application. 
The cells were left to grow for 3 days in the sample exposed media, along with controls. After 
3 days the media was changed and MTT was added to the wells. Alive and healthy cells will 
break down the MTT to soluble Formazan which also can be measured by spectroscopy. The 
cells were therefore lysed after 4 hours of cultivation and the absorbance was read by a 
microplate reader. After comparing to a negative control (cells grown in just pure media) the 
cytotoxicity of the material could be evaluated.  
 
3.6. Pilot in vivo study 
 
In Paper 1, a pilot in vivo study (approved by the Local Ethical Committee for Laboratory 
Animals) was performed where the hydrogels were placed in pockets surgically cut on to the 
back of seven female Sprague-Dawley rats. Each rat had six pockets with control hydrogels in 
three pockets and AMP-modified hydrogels in the other three. One set of hydrogels were left 
without bacteria and to one set 50 µl of S. aureus of a concentration of 104 CFU/ml were added 
and to the last set 50 µl of S. aureus of a concentration of 2*106 CFU/ml were added. Animals 
were sacrificed after 24 or 72 hours and the exudate around the hydrogels were gathered as 





4. Result and discussion 
 
4.1. Material preparations 
 
A general scheme of the production process of both the hydrogel sheets and the particles is 
presented in Figure 5. In Figure 5a, it is shown that the mixed components first formed a very 
foamy gel. The same gel after it has been stored at 4 °C over a weekend can be seen in Figure 
5b and c. Depending on the temperature of the gel at this stage, it will change from being a 
liquid at 4 °C to being a gel at room temperature. This behavior can be utilized to ease casting 
or even 3D-printing to form the gels into desired shapes. Since the gel then can be cross-linked 
solid, as seen in Figure 5d, the desired final shade of the material is easy to manipulate. The 
hydrogel sheets and discs studied in Paper 1 was however not made exactly like Figure 5d. 
Instead, the foamy gel of Figure 5a was centrifuged and placed between glass slides where it 
was left for a day sealed away from light and then cross-linked. This resulted in a bit more air 
bubbles but otherwise similar appearance. The particles used in Paper 2 were made using the 
cross-linked hydrogels as the starting material. After the hydrogels had been washed for a few 
days they were grinded up, reduced further in size using an ultra-turrax and sonicated to form 
the slurry seen in Figure 5e. For some experiments it was necessary to have the particles 
completely dry. The particles were then freeze-dried to maintain the structure as much as 
possible. The results from this can be seen in Figure 5f. 
Both the hydrogel sheets and the particles were hydrophilic and absorbed water into their 
structures. Roughly 90% of the weight is water in fully swollen state. From the UV-vis studies 
we do, however, know that the AMP modification was rather different for the two systems. 
The hydrogel sheets, when modified as 1 mm thick discs, took up 1 mg of AMP per gram of 
swollen hydrogel. The particles, on the other hand, took up 3.3 mg of AMP per gram of swollen 
particles. This strongly indicates that the available surface is a greater driving force for the 





4.2. Material characterization 
 
4.2.1. Chemical characterization 
 
Figure 6 shows the FTIR results of pure AMP powder, freeze-dried control particles, freeze-
dried AMP-modified particles, and the DA-PF127 powder. Figure 6a shows the full spectra of 
the four samples. The main thing one can tell here is that the Pluronic F-127 fingerprint between 
500-1500 cm-1 was maintained for all the Pluronic containing samples, indicating that no major 
changes were made to the structure. In Figure 6b, the spectra have been zoomed in on 1520-
1820 cm-1 to closer illustrate changes in the ketone area. Between the DA-PF127 sample and 
the freeze-dried control particles there was a slight peak shift and broadening of the peak at 
1725 cm-1 in the DA-PF127 sample to 1735 cm-1 in the control particles sample. In the DA-
PF127 sample we have a conjugated ester bond and the two most likely scenarios for the type 
of ketone in the control particles are a non-conjugated ester or a carboxylic acid group. Both 
of these bonds are expected to give rise to absorbance at higher wavenumbers. It is therefore 
very difficult to claim what type is contributing to the observed change strictly from the data. 
However, we know that the hydrogel is in fact solid-like, which can only be achieved if the 
Figure 5. Images taken of the different steps of the particle formation process. (a) The gel mixture directly after 
mixing. (b) The gel solution at 4 °C after being stored in the fridge for 72 h. (c) The same solution after it has 
equilibrated to room temperature. d) The hydrogel after it has been cross-linked between two glass slides. (e) The 
particles made from the hydrogels by grinding, using an ultra-turrax and sonicating. (f) The particles after they 
have been AMP-modified and freeze-dried. 
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majority of the ketone groups are in an ester bond. It is therefore speculated that only a minority 
of the ketones are found as carboxylic acids. The peak location does not shift significantly for 
the AMP-modified particles, further strengthening this speculation. There is however a slight 
difference in peak appearance, as the peak at 1735 cm-1 for the AMP-modified particle is not 
as deep and have a rounder appearance. This could be due to the fact that the carboxylic acids 
in the mixture forms peptide bonds through EDC/NHS activation. The amides of the peptide 
bonds in the peptide itself are giving rise to the broader peak at ~1660 cm-1 found in both AMP 
containing systems. As the freeze-dried AMP-modified particles are completely void of water 
it is safe to say that the found AMPs are incorporated into the LLCs. It is however more difficult 
to claim anything regarding the covalent attachment from this data, especially since potential 
peptide bonds formed by the carboxylic acid groups would be engulfed by the amide 
contribution of the peptide itself. 
 
 
These observations are further supported by the results from the Raman spectroscopy, seen in 
Figure 7. Powder from the same samples were examined, and the main peaks that change in 
between the samples are marked with arrows in the figure. Between the DA-PF127 sample and 
the control particles there were two peaks at ~1640 cm-1 and ~1730 cm-1 that disappeared. 
These peaks correspond to C=C bonds, which fits well with the vinyl group of the acrylate. 
Figure 6. FTIR results of pure AMP (purple), freeze-dried AMP-modified particles (green), freeze-dried control 
particles (blue) and the DA-PF127 (red). (a) The full spectra. (b) A zoomed in section of wavenumbers between 
1520-1820 cm.-1. Two lines have been drawn in b) where the left one is drawn at 1735 cm-1 and the right one is 
drawn at 1725 cm-1. 
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Their disappearance marks that this is how the system is cross-linked together. Between the 
control and the AMP-modified samples there are three small new peaks at ~750 cm-1, ~1010 
cm-1, and ~1550 cm-1 that appear in the AMP-modified sample. All of these peaks are also 
found as narrow strong peaks of the pure AMP sample, further indicating the incorporation of 
AMP into the material. The peak at 1010 cm-1 is most likely due to the guanidino groups of the 
arginine amino acids and the peak at 1550 cm-1 is most likely due to the indole groups of the 
tryptophan amino acids. That the peaks are so small in the AMP-modified samples, for both 
FTIR and Raman, is due to the fact that the peptides only contribute to roughly 3.3% of the dry 
weight of the particles. The spectra are therefore mainly consisting of the contributions from 
the PF-127 and the interactions between the structure and the peptides was very difficult to 
determine. 
 
4.2.2. Structural characterization 
 
The results obtained from the SAXS measurements can be seen in Figure 8. The clear 
diffraction peak at these q-values in all the spectra indicate that an ordered nanostructure, most 
likely a micellar cubic structure was indeed present in all the samples [1, 69]. Based on prior 
literature data on the same composition, it is known that DA-PF127 and water forms a micellar 
cubic structure. Furthermore, it was evident that the same structure was found for the freshly 
cross-linked hydrogel sheets (30 wt% Pluronic, 70 wt% water) as for both of the freeze-dried 
particles. This indicates that the LLC was not affected by neither the steps taken in order to 
make the particle nor that the AMP-modification made an observable difference in the 
structure. This is not really surprising, since the structure is fully cross-linked before the 
addition of peptides is made. There was a slight peak shift observed for the fully swollen 
particles compared to the other spectra. The peak shifted roughly 0.005 Å-1 to a higher q-value. 
This indicates that the spacing has become smaller in between the structure. The explanation 
for this could be that the micelles of the LLCs has swollen by taking up water, but since the 
structures are cross-linked together the structures cannot move too much away from each other, 
effectively making the distance between them smaller.  
A number of reasons may contribute to the low SAXS signal and thereby the absence of 
secondary peaks obtained from the materials namely low sensitivity of the SAXS instrument 
and in-situ drying of the materials during measurements leading to higher probability of 
random scattering. It is therefore not possible to draw any conclusions regarding the structure 
solely from the plots. However, the phases of Pluronic F-127 have been thoroughly studied, 
and the concentration used to make the gels has been determined to be in the micellar cubic 
phase. Since the peaks did not change in appearance it can be deducted that this phase is 
maintained throughout the process. This means that both the sheets and particles are made up 
of self-assembled Pluronic F-127 in micellar cubic LLCs. This is further supported by earlier 
work by our group which have look in to similar composition of the DA-PF127 and showed 
that the micellar cubic structure was present in the gel formed by 35 wt% DA-PF127 and 65 





Figure 7. The measured Raman spectra for the pure AMP (purple), freeze-dried AMP-modified particles (green), 
freeze-dried control particles (blue), and DA-PF127 (red). The black arrows indicate the peaks that are changing 





The size distribution of the particles developed in Paper 2 is presented in Figure 9 and Figure 
10. The size distribution of the whole set of particles straight after they were made can be seen 
in Figure 9. It is evident that a very broad distribution was obtained. Depending on whether a 
volume-based distribution or a number-based distribution was used, the appearance changed 
significantly. What this means is that the vast majority of the mass can be found in particles 
with a size between 100-500 µm, while the majority of the particles have a size between 2-30 
mm. This means that if a particle was chosen randomly it is more likely to be a particle with 
this size.  
 
Figure 8. The SAXS diffractograms for the cross-linked hydrogels (30 wt% DA-PF127, 70 wt% water), freeze-
dried control particles, freeze-dried AMP-modified particles, and fully swollen control particles. All samples were 




The size distribution of a subset of particles that have gone through a 6 µm filter is presented 
in Figure 10, where control particles are presented in Figure 10a and AMP-modified particles 
are presented in Figure 10b. The data of the control particles showed two clearly distinct  
distributions, between 20-60 nm and 90-350 nm. The three consecutive runs showed very 
similar results indicating that the particles at least were stable for these shorter periods of time. 
The data for the AMP-modified particles, however, showed a less clear distribution. The 
distribution of the three consecutive runs were a bit different in between measurements, with a 
broader span (20-700 nm) compared to the control particles. This indicates that the AMP-
modified particles are not stable even for the short time of the experiment. The explanation to 
this change of distribution is speculated to be due to the properties of the AMPs themselves. 
The tryptophan end-tag is very hydrophobic which could cause the particles to become ‘sticky’. 
This means that the hydrophobic effect might cause the tryptophan groups of the peptides 
attached to different particles to aggregate, causing the observed shift to bigger sizes. The 
arginine groups of the peptides, on the other hand, should work as repulsive forces, due to their 
positive charges, acting against aggregation. This could be the reason why the second run has 
a distribution more like that of the control particles and why run 1 and 3 have a broader 
distribution. Further experiments are however necessary to study the interaction. 






4.3. Antimicrobial efficacy 
 
Images of the surfaces of control and AMP-modified hydrogel discs developed in Paper 1 after 
24 hours of incubation with S. aureus, S. epidermidis and P. aeruginosa are presented in Figure 
11. It was clear that the number of alive cells (stained green) was found in much higher 
quantities on the control samples compared to the AMP-modified samples. On the contrary, 
the number of dead cells (stained red) was much higher on the AMP-modified samples 
compared to the respective control samples. The reduction of alive cells strongly indicates that 
biofilm formation on top of the hydrogels was effectively prevented by binding AMPs to the 
hydrogels. The increase of dead cells strongly indicate that the biofilm prevention was due to 
the bacteria being killed. The most likely mechanism of action is contact killing, which also 
explains why there are some alive bacteria found on the AMP-modified samples. When the 
hydrogel samples are put in a solution there will always be a deposition of new bacteria to the 
surface. At some point this will result in the surface being saturated and therefore not being 
able to kill the new bacteria. Noticeable is that the gram-negative bacteria P. aeruginosa did 
not appear to cultivate the control hydrogel surfaces (Figure 11c) in the same extent as the two 
other bacteria strains did (Figure 11a and b). Since all of these bacteria are commonly found in 
infected wounds on humans, antibacterial activity against them is of high relevance with the 
application in mind. 
 
 
Figure 10. Size distributions (intensity-based)  measured by DLS of the filtrated (<6 µm) particles. (a) The size 
distribution of non-modified control particles over three consecutive 60 second runs. (b) The size distribution 




In an attempt to easily get an overview of the potential antibacterial effect, a macro in the 
software Fiji was used to calculate the fraction of the surface that was green (alive cells) and 
the fraction that was red (dead cells). The macro was not perfect but with enough images it 
painted a clear picture. The graphs for the calculated values for the study against S. aureus, S. 
epidermidis and P. aeruginosa can be seen in Figure 12. The results show more of the same, 
where the amount of alive cells was lower for all bacteria on top of the AMP-modified samples 
compared to the control samples. Furthermore, the amount of dead cells was also greater for 
the AMP-modified samples compared to the control samples. 
Figure 11. Images of bacteria on top of hydrogels that has been cultivated for 24 hours and where the alive cells 
have been stained green by SYTO 9 and the dead cells has been stained red by Propidium iodine. (a) S. aureus 
on top of a control hydrogel. (b) S. epidermidis on top of a control hydrogel. (c) P. aeruginosa on top of a control 
hydrogel. (d) S. aureus on top of an AMP-modified hydrogel. (e) S. epidermidis on top of an AMP-modified 




The same test was also done against two antibiotic resistant bacterial strains. The results from 
these tests can be seen in Figure 13 and Figure 14. For the MRSA it was clear that it had a good 
effect, and the results did not differ much from that of non-resistant S. aureus. The amount of 
alive bacteria significantly decreased on the surface and the amount of dead bacteria 
significantly increased. For the MDR-E. coli the results were similar to the other gram negative 
bacteria tested. There were not a lot of attached bacteria to the control surface and it was 
therefore not much less alive bacteria found on the AMP-modified surface. It was, however, 
significantly more dead bacteria found on the AMP-modified surface for this strain, strongly 
indicating that the AMP-modified surface was fully capable of killing the resistant bacteria.  
 
Figure 12. Quantitative analysis of the surface coverage of alive and dead cells of  S. aureus (a), S. epidermidis 
(b), and P. aeruginosa (c) on top of control and AMP-modified  hydrogels. The values were obtained by analyzing 
the fluorescent images from n=9 samples using Fiji software. * indicates a statistically significant difference 





Figure 14. Quantitative analysis of the surface overage of alive and dead cells of  (a) MRSA and (b) MDR-E. coli 
on top of control and AMP-modified  hydrogels. The values were obtained by analyzing the fluorescent images 
from n=9 samples using Fiji software. * indicates a statistically significant difference compared to the 
corresponding control with p<0.05, and the error bars show the standard deviation. 
Figure 13. Images of bacteria on top of hydrogels that has been cultivated for 24 hours and where the alive 
cells have been stained green by SYTO 9 and the dead cells has been stained red by Propidium iodine. (a) 
MRSA on top of a control hydrogel. (b) MDR-E. coli on top of a control hydrogel. (c) MRSA on top of an 
AMP-modified hydrogel. (d) MDR-E. coli on top of an AMP-modified hydrogel. The scale bars in all images 
are 50 µm. 
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The antimicrobial activity of the pure AMP and the AMP-modified particles (Paper 2) in 
solution against S. aureus, S. epidermidis and P. aeruginosa is presented in Table 1. The pure 
AMP showed a very low MIC for both S. aureus and E. coli but unsurprisingly a bit higher 
concentration was necessary in order to stop the growth of P. aeruginosa. The AMP-modified 
particles showed a similar trend but when recalculated to the corresponding peptide 
concentration of the particles it was evident that the activity was a bit lower when bound to the 
particles. This is not really surprising, as the peptides have lost some degree of freedom in 
terms of restricted moving. For both S. aureus and E. coli the concentrations are still relevant, 
and 30 mg/ml of particles is still clearly a solution. Up towards 250 mg/ml of particles and the 
solution is starting to become more of a slurry, which is not really suitable for all applications. 
Important to keep in mind is that the smallest particles (<6 µm) are not present in the solution, 
which, if present, could have resulted in lower MIC, since they have a better mobility. 
 
Table 1. The measured MIC values against three bacterial strains. N=3 and if different concentrations were seen 
at different runs, an interval of concentrations is presented. 
Name S. aureus E. coli P. aeruginosa 









12 – 51 µM 24.4 – 53.4 µM 213 – 427 µM 
 
Perhaps a more relevant experiment for wound care applications is the agar plate model from 
which the results against S. aureus are presented in Figure 15. Figure 15a shows an image taken 
of an agar plate after cultivation with the control spread on the left and the AMP-modified 
spread on the right. Straight from the appearance it was clear that the bacteria were growing 
and thriving around the control particles, which was not the case around the AMP-modified 
particles as the color was much more transparent. This was also clear from the measured CFU 
count from biopsy punches taken from the middle of the spreads. The results presented in 
Figure 15b revealed that the AMP-modified particles lowered the bacterial load by log4 
compared to the control particles. The control samples had a bacterial load of 2.5 ± 1.0 *108 
CFU/ml and the AMP-modified samples had a bacterial load of 1.7 ±  2.5 *104 CFU/ml. 
Recalculated to a surface concentration, this corresponds to 1.98 ± 0.79 *109 CFU/cm2 for the 
control samples and 1.35 ± 1.98 *105 CFU/cm2 for the AMP-modified samples. This potential 
to greatly reduce the bacteria present in a wound could make wonders, giving the leukocytes 
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of the inflammatory response a breathing room and only having to deal with stragglers not 
caught by the particles.  
 
 
To demonstrate the covalent attachment of the AMPs to the hydrogel discs used in Paper 1, a 
zone of inhibition study was performed, and the result is presented in Figure 16. Hydrogel discs 
were either left non-modified or activated by EDC/NHS followed by AMP modification, or 
they were placed in the AMP solution without priorly being activated by EDC/NHS (named 
here as physically absorbed AMPs). After cultivating overnight on top of an agar plate streaked 
with S. aureus the images in Figure 16 were taken. No clear zone of inhibition was seen around 
neither the control hydrogels nor the covalently AMP-modified hydrogels. A clear release from 
the physically absorbed AMPs was, however, evident although it was not the most perfect zone 
of inhibition (i.e. there are some clear colonies close to the discs and the edge of the zone in 
not sharp). The covalent attachment reaction is never 100%,  but the non-attached peptides that 
are not washed away of the covalently modified sample are evidently in such a low 
concentration that they do not show an antibacterial effect. From these results it can therefore 
be deducted that the majority of the AMPs taken up by the hydrogels activated by EDC/NHS 
were covalently attached to the LLCs. A similar reasoning can be made for the AMP-modified 
particles of the agar plate model in Figure 15 as no clear zone indicating release of peptides 
was present around the AMP-modified particle spread. 
Figure 15. (a)  An image of the top of an agar plate cultivated over night with S. aureus. Control particles are 
spread on the left and AMP-modified particles are spread on the right. The scale bar is 1 cm. (b) The measured 
CFU/ml of biopsy punches taken from the middle of the spreads shown in a). n=9 and the error bars show the 





To study the potential interaction between the particles developed in Paper 2 and the bacteria, 
cryo-EM was implemented. This technique makes it possible to study biological interactions 
within samples as it is locked in place by plunge-freezing, for example a bacterial solution, in 
liquid ethane and then keeping it in liquid nitrogen throughout the imaging process. As 
described earlier, this study aimed at investigating the interactions between the AMP-modified 
hydrogel particles and the bacteria at the sub micrometer level. The images obtained from the 
study are presented in Figure 17. From Figure 17b and Figure 17d it is clear that there is an 
attraction between the particles and the bacterial surface. The particles appear to be deformed 
close to the bacteria and in Figure 17b the cell wall/membrane of the bacterium closest to the 
particle even appear to be distorted somewhat (marked with a red arrow in the image). This 
suggests that the antibacterial mechanism have to do with interactions with the cell 
wall/membrane of the bacteria. A few limitations of this analysis were however evident, the 
bacterial strain used (S. aureus), given their large size (≈1 µm)  presented as thick large spheres 
thereby minimizing the contrast required for capturing clear transmission electron 
micrographs. Additionally,  as the ice that formed around the cells was quite thick, it gets darker 
and darker closer to the cells. This is also speculated to be the reason behind the fact that only 
particles that match the size distribution of bigger particles (~250 nm) were found close to the 
bacteria. Smaller particles were seen elsewhere in the samples and it is speculated that they are 
also present closer to the bacteria but does not show up due to the ice. It would be of great 
interest to study the interaction further using a strain where the cells are a bit smaller, like mini-
E- coli. It would also be beneficial to have a higher concentration of particles at this size as it 
was time consuming finding interactions. 
Figure 16. Images taken of (a) control hydrogel, (b) hydrogel with physically loaded AMPs, (c) hydrogel with 
covalently attached AMPs cultivated overnight on agar plates spread with S. aureus. All hydrogel discs were 





Figure 17. Cryo-EM-images taken of a solution of  S. aureus that have been cultivated for 1 h together with AMP-
modified particles. The scalebars are 100 nm in all images. The brightness has been adjusted in the images for 
better clarity. b) is a zoomed in image of a), and d) is a zoomed in image of c). The red arrow indicates an area 
where possible distortion in the membrane is visible (the red cross is a burned-in graphic, please disregard this). 
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4.4. Proteolytic stability 
 
To analyze the stability against proteolytic degradation, the hydrogel discs of Paper 1 was 
placed in 20% serum and was removed from the serum at regular intervals, washed, and then 
cultivated for 24 h with S. aureus. The surfaces of the hydrogel discs were analyzed by 
LIVE/DEAD staining and the fraction of dead bacterial cells are presented in Figure 18. It was 
clear that the activity was maintained for the first 10 hours and that it was less active after 1 
and 2 days in serum, but still showing an effect. The control and AMP-modified surfaces 
looked identical after 5 days, which indicates that somewhere between 2 and 5 days the peptides 
were degraded to such an extent where no antibacterial potency were present. These results 
show that by attaching the AMPs to LLCs of a hydrogel, the peptides maintain antibacterial 
activity for at least two days in 20% serum, which is a considerable higher lifetime compared 
to the AMPs of the innate immune system [71-73]. However, if the hydrogels were to be used 
in a wound dressing it is important to keep in mind that a change of dressing is necessary if 





The cytotoxicity of the hydrogels developed in Paper 1 was evaluated by an MTT assay against 
primary human dermal fibroblasts. The result from this test is presented in Figure 19. The cells 
cultivated in the sample exposed media from both the control and AMP-modified samples had 
a significantly higher viability over the 70% cut-off (substances that cause a viability less than 
Figure 18. The proportion of dead S. aureus on top of control and AMP-modified hydrogel surfaces after 24 h 
cultivation. The hydrogels were incubated in 20% serum prior to the cultivation with bacteria and taken out from 
the serum and washed with water according to the times on the x-axis. n=4 and the error bars are the standard 
deviation for the images taken of all samples. * indicates a significant difference compared to control of same 
time point, p<0.05. 
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70% is considered to be cytotoxic). No difference was found in between the two hydrogel types. 
While there was a significantly higher standard deviation observed for the samples, the average 
viability was just a few percent lower than that of the negative control (cells cultivated in pure 
media). This test strongly indicates that no substances are leaching out from the materials at 
toxic levels during the three days of extraction.  
 
 
4.6. Pilot in vivo study 
 
The results from the pilot in vivo study are presented in Figure 20. Although the results support 
the overall hypothesis of the antibacterial activity of the materials, given the small scale of the 
study, the results need to be verified in large scale studies. However, the trend for the pilot 
study showed that the bacteria found on the implanted hydrogels were lower for both starting 
concentrations at both time intervals. This indicates that the AMP-modified hydrogels 
maintained their antibacterial activity even when implanted in rats. The results from the 
exudate were not as straight forward. The 24 hour evaluation with a 104 CFU/ml starting 
concentration showed higher CFU/ml for the AMP-modified hydrogel compared to the control. 
However, with a higher starting concentration (2*106 CFU/ml) there was a reduction in bacteria 
Figure 19. The cell viability of primary human dermal fibroblasts cultivated in sample exposed media compared 
to the negative control (cells in pure media). The red striped line indicates 70% cell viability, and the error bars 




for the AMP-modified hydrogels. To study the effect of AMP-modified hydrogels on the 




Figure 20. Results for the CFU/ml from the pilot in vivo study. (a) shows the results from the pockets with a 
starting concentration of 104 CFU/ml. (b) shows the results from the pockets with a starting concentration of 
2*106 CFU/ml. The ‘control’ is the non-modified hydrogels, and the ‘test’ is the AMP-modified samples. The blue 
arrow of the 24 h control samples means that the agar plates had a too high bacterial load to count individual 
colonies for the dilutions used. 
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5. Concluding remarks 
 
The work presented in this thesis has shown two approaches to develop antibacterial materials 
consisting of cross-linked lyotropic liquid crystals with covalently attached antimicrobial 
peptides. The first concept is built on soft hydrogel sheets/discs that consists of 90 wt% water, 
which translated to a wound dressing would provide a wound with a moist environment while 
also lowering the bioburden. The results demonstrated that antibacterial effect against clinically 
relevant strains and even antibiotic resistant strains were achieved. By covalently attaching the 
antimicrobial peptides to the material they gained a protection against proteolytic degradation. 
This was demonstrated as antimicrobial activity was maintained for up to two days in serum. 
The antibacterial efficacy was achieved without causing cytotoxicity against primary human 
dermal fibroblasts, an important cell in the wound healing process. 
The second concept is built on further increasing the antibacterial effect while also providing 
the potential of using an antibacterial liquid formulation, that offers a higher surface area and 
the potential to be used for deeper or harder to treat wounds. This was achieved by processing 
the cross-linked lyotropic liquid crystals into particles with a broad size distribution that was 
again modified with antimicrobial peptides. The micellar cubic structure was maintained 
throughout the procedure and the peptides were shown to covalently attach to the particles. 
Minimum inhibitory concentration-studies showed that a good antibacterial effect was 
achieved against both the gram-negative E. coli and the gram-positive S. aureus. In a higher 
concentrated slurry, a great reduction of bacterial load was observed in an agar plate model. 
This could provide a wound with a great protection against infection. Furthermore, cryo-EM 
studies indicated that the particles exerted their antibacterial effect by strongly interacting with 
the bacterial cell wall/membrane. 
Both concepts showed a good antibacterial effect without using traditional antibiotics. More 
research like this will hopefully contribute to the development of new treatments that will get 






6. Future perspectives 
So far, the work has been focused on only one peptide. It would be of great interest to evaluate 
other peptides with the same LLC base. Furthermore, the work has only looked into one type 
of microbe – bacteria – as this is most relevant for wound infections. AMPs are however known 
to also be effective against some fungi and some enveloped viruses. It would therefore be of 
outmost interest to see what – if any – the effect against these microbes might be and how it 
might work.  
Some AMPs are also known to activate certain parts of the wound healing process. It would 
therefore be of interest to perform further studies to investigate if the materials developed in 
this thesis can be used also for improving the wound healing. Along these lines it would also 
be of interest to investigate if the AMP-modified LLCs could also be used for drug 
administration for a dual benefit. 
Finally, it would be a great benefit to have better control of the size of particles that were 
developed in this thesis. So far, a very rough top-down approach has been used to make the 
particles. It may be possible to utilize a more bottom-up approach to at least make particles of 
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